Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes


Oldfield, Lucy ORCID: 0000-0002-0839-402X, Evans, Anthony ORCID: 0000-0001-8547-1730, Rao, Rohith Gopala, Jenkinson, Claire, Purewal, Tejpal, Psarelli, Eftychia E, Menon, Usha, Timms, John F, Pereira, Stephen P, Ghaneh, Paula et al (show 3 more authors) (2022) Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes EBIOMEDICINE, 75. 103802-. ISSN 2352-3964, 2352-3964

Access the full-text of this item by clicking on the Open Access link.
[thumbnail of Oldfield et al EBM Revised Manuscript_CLEAN.docx] Text
Oldfield et al EBM Revised Manuscript_CLEAN.docx - Author Accepted Manuscript
Download (518kB)

Abstract

Background: Screening for pancreatic ductal adenocarcinoma (PDAC) in populations at high risk is recommended. Individuals with new-onset type 2 diabetes mellitus (NOD) are the largest high-risk group for PDAC. To facilitate screening, we sought biomarkers capable of stratifying NOD subjects into those with type 2 diabetes mellitus (T2DM) and those with the less prevalent PDAC-related diabetes (PDAC-DM), a form of type 3c DM commonly misdiagnosed as T2DM. Methods: Using mass spectrometry- and immunoassay-based methodologies in a multi-stage analysis of independent sample sets (n=443 samples), blood levels of 264 proteins were considered using Ingenuity Pathway Analysis, literature review and targeted training and validation. Findings: Of 30 candidate biomarkers evaluated in up to four independent patient sets, 12 showed statistically significant differences in levels between PDAC-DM and T2DM. The combination of adiponectin and interleukin-1 receptor antagonist (IL-1Ra) showed strong diagnostic potential, (AUC of 0.91; 95% CI: 0.84-0.99) for the distinction of T3cDM from T2DM. Interpretation: Adiponectin and IL-1Ra warrant further consideration for use in screening for PDAC in individuals newly-diagnosed with T2DM. Funding: North West Cancer Research, UK, Cancer Research UK, Pancreatic Cancer Action, UK.

Item Type: Article
Uncontrolled Keywords: Pancreatic cancer, Early detection, Type 3c diabetes, Blood biomarkers, Adiponectin, IL-1Ra
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Systems, Molec & Integrative Biology > Inst. Systems, Molec & Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 24 Jan 2022 16:55
Last Modified: 16 Jun 2026 11:48
DOI: 10.1016/j.ebiom.2021.103802
Open Access URL: https://www.thelancet.com/pdfs/journals/ebiom/PIIS...
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3147566
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.
Altmetric
CORE (COnnecting REpositories)